CT versus MRI in Treatment Response Assessment with LI-RADS: The Choice Is Unclear

Radiology. 2021 May;299(2):346-348. doi: 10.1148/radiol.2021210049. Epub 2021 Mar 2.

Authors

Mustafa R Bashir¹, Mishal Mendiratta-Lala¹

Affiliation

¹ From the Center for Advanced Magnetic Resonance Development, Duke University Medical Center, 200 Trent Dr, Durham, NC 27710 (M.R.B.); and Department of Abdominal and Cross-Sectional Interventional Radiology, University of Michigan School of Medicine, Ann Arbor, Mich (M.M.L.).

PMID: 33656383
DOI: 10.1148/radiol.2021210049

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Carcinoma, Hepatocellular*
Contrast Media
Humans
Liver Neoplasms*
Magnetic Resonance Imaging
Tomography, X-Ray Computed

Substances

Contrast Media